Communication to industry on ranitidine-containing medicines

Communication to industry on ranitidine-containing medicines

The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulatory agencies, are reviewing all ranitidine-containing medicines with the following Active Pharmaceutical Ingredient; ranitidine. SAHPRA previously issued a media release regarding the recall and quarantine of ranitidine containing medicines (29 October 2019 and 20 January 2020).

2020 Oct

Download latest version
File Type: pdf
Category: Communication to industry
Unit: General ECTD & human medicines